ClinicalTrials.Veeva

Menu

Enhanced Recovery for Patients Undergoing Radical Cystectomy.

M

Menoufia University

Status

Completed

Conditions

Post Procedural Discharge

Treatments

Other: ERAS
Other: Non ERAS pathway

Study type

Interventional

Funder types

Other

Identifiers

NCT05210673
ERAS in radical cystectomy

Details and patient eligibility

About

Investigators hypothesize that with the use of enhanced recovery of surgery (ERAS), the postoperative hospital stay after radical cystectomy is reduced, and also postoperative complications are decreased.

Full description

Radical cystectomy (RC) is believed to be associated with high morbidity and prolonged length of hospital stay even with advances in perioperative medical care. Enhanced Recovery After Surgery (ERAS) pathways are multidisciplinary, multimodal evidence-based approaches to perioperative protocol by which patients are treated. The most important aims of this multimodal approach are modifying as many of the factors contributing to the morbidity of RC as possible, the improvement of patients' preoperative status, and the perioperative maintenance of homeostasis by minimizing stress response and inflammation to improve patient outcomes and decrease the length of inpatient hospital stay. The investigators hypothesize that with the use of enhanced recovery of surgery (ERAS), the postoperative hospital stay after radical cystectomy is reduced, and also postoperative complications are decreased.

Enrollment

50 patients

Sex

All

Ages

40 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age: 40-85 years.
  • Adequate cognitive state (able to understand and collaborate)
  • American society of anesthesia (ASA) I, II and III.

Exclusion criteria

  • ASA IV

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

50 participants in 2 patient groups

group A
Experimental group
Description:
non ERAS pathway
Treatment:
Other: Non ERAS pathway
group B
Active Comparator group
Description:
ERAS pathway
Treatment:
Other: ERAS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems